Rechercher

Quantum technologies could be a game-changer in the digital transformation of health care. By enabling much faster and more complex data analysis, they could open the door to the accelerated discovery and development of novel therapeutics, improved diagnostics and treatments, including for rare and complex diseases, genuinely personalised medicine, and better data-driven health policy planning. However, as is also the case in other sectors, quantum technologies come with risks, particularly to cybersecurity ...

Au cours de la période de session de décembre, le Parlement européen devrait se prononcer en deuxième lecture sur une proposition de la Commission européenne visant à renforcer la coopération, au niveau de l’Union, entre les États membres en matière d’évaluation des technologies de la santé. L’amélioration de la coopération profiterait aux systèmes de santé nationaux et aux fabricants de médicaments et de dispositifs médicaux, puisque les procédures d’approbation seraient simplifiées, tout en bénéficiant ...

Sequencing and analysis of the human genome – all the genetic information stored in our DNA – provide us with understanding about a person's ancestry, health and other traits. Thanks to DNA sequencing, medicine and the life sciences are able to predict and cure diseases. As DNA sequencing technologies continuously improve and become less costly, what if we all soon possessed our personal, smart DNA sequencers and apps to analyse our DNA?

The coronavirus (Covid-19) pandemic remains a major threat to public health in the European Union (EU). Testing is considered an essential aspect of the response to the pandemic. There are different types of coronavirus tests, each having its own merits and limitations. The timing of tests is also critical. Among the tests that detect current infection, (rapid) antigen tests have recently come to the fore. In view of a resurgence of coronavirus cases, the European Commission adopted on 28 October ...

The current drug development paradigm is too drug-centred and does not sufficiently take into account the patients that will receive the new therapy. This has led to the emergence of a research gap between the pre-approval development of medicines and their post-approval use in real-world conditions. In this study, semi-structured interviews were performed with experts in drug development process. It offer an overview concerning the concept of treatment optimisation and potential policy options.

This report summarises the presentations and discussions of a workshop on the use of robots and AI in healthcare, held at the European Parliament in Brussels on Tuesday 19 February 2019. The aim of the workshop was to provide background information and advice for Members of the ENVI Committee on the status and prospects of applying robotic and artificial intelligence (AI) based technologies in healthcare. The first part of the workshop focused on the practical application of AI and robots in healthcare ...